DD Support Board and Research Team

[DragonBear]

SEC warns pharma companies to be honest about FDA correspondence

Andrew Ceresney, the SEC's enforcement director, said the agency has seen a lot of problems with disclosures by pharmaceutical companies, including on 8-Ks

Well Andrew, that wasn't a problem for GWPC... they just didn't bother to file an 8K. Instead they put out bogus PRs about seeking FDA approvals, and the SEC couldn't do a damn thing about it.

Yes Andrew, your SEC did suspend GWPC, but it likely had little to do with their bogus PRs concerning the FDA. Rather the dummy CEO was delinquent in the 10K-10Q filings, and dumping in violation of Rule 144. And who knows how long that would have gone on, if the pump hadn't concerned the hot button topic of Ebola.

The likes of GWPC is an example of how impotent the SEC has become when combating P&Ds. They can warn about 8K content all they want. The scams just avoid filing an 8K. Or better yet cutting across sectors, avoid mentioning anything material about recent operations in a 10K-10Q. An example remains TRII. The CEO issues announcements about the latest silver assays on his website, and then just avoids mentioning said assays in the 10K. Presto, there is nothing for the SEC to question.

So Andrew of the SEC, you have surely scared the willies out of the pretend OTC Pharma stocks with your warning...NOT!